KTE-X19 Anti-CD19 CAR T-Cell Therapy in Adult Relapsed/Refractory ALL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
KTE-X19 Anti-CD19 CAR T-Cell Therapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia: ZUMA-3 Phase 1 Results
Blood 2021 Apr 07;[EPub Ahead of Print], BD Shah, MR Bishop, OO Oluwole, AC Logan, MR Baer, WB Donnellan, KM O'Dwyer, H Holmes, ML Arellano, A Ghobadi, JM Pagel, Y Lin, RD Cassaday, J Park, M Abedi, J Castro, DJ DeAngelo, AK Malone, R Mawad, G Schiller, JM Rossi, A Bot, T Shen, L Goyal, RK Jain, R Vezan, WG WierdaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.